<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48">
 <label>48.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Peters</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Brandl</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Lindbloom</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>Scallan</surname>
    <given-names>CD</given-names>
   </name>
   <name>
    <surname>Trager</surname>
    <given-names>GR</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans</article-title>. 
  <source>Vaccine</source> (
  <year>2013</year>) 
  <volume>31</volume>:
  <fpage>1752</fpage>â€“
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.01.023</pub-id>
  <?supplied-pmid 23357198?>
  <pub-id pub-id-type="pmid">23357198</pub-id>
 </mixed-citation>
</ref>
